LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML

[1]  P. Boor,et al.  Evolving complexity of MIF signaling. , 2019, Cellular signalling.

[2]  John A. Taylor,et al.  MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential , 2019, Nature Reviews Urology.

[3]  Chenyue W. Hu,et al.  A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia , 2019, Nature Biomedical Engineering.

[4]  G. Pinkus,et al.  Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity , 2019, Cell.

[5]  U. Bandyopadhyay,et al.  Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74–NF-κB signaling , 2018, The Journal of Biological Chemistry.

[6]  S. Neubauer,et al.  Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial , 2018, PloS one.

[7]  Chenyue W. Hu,et al.  Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic , 2018, Expert review of proteomics.

[8]  M. Andreeff,et al.  Role of MSC-derived galectin 3 in the AML microenvironment. , 2018, Biochimica et biophysica acta. Molecular cell research.

[9]  H. Qian,et al.  Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice. , 2018, Blood advances.

[10]  V. Hogan,et al.  Galectin-3 and cancer stemness , 2018, Glycobiology.

[11]  M. Konopleva,et al.  Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival , 2018, Haematologica.

[12]  William L. Redmond,et al.  The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment , 2018, Oncoimmunology.

[13]  D. Cheresh,et al.  Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers. , 2017, Cancer discovery.

[14]  A. Simon,et al.  Mechanistic roles of autophagy in hematopoietic differentiation , 2017, The FEBS journal.

[15]  F. Di Palma,et al.  MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia. , 2017, Cancer research.

[16]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[17]  R. Davis,et al.  Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia. , 2016, Blood.

[18]  B. Schröder.  The multifaceted roles of the invariant chain CD74--More than just a chaperone. , 2016, Biochimica et biophysica acta.

[19]  R. Davis,et al.  Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells. , 2016, Biochimica et biophysica acta.

[20]  P. Ruvolo.  Galectin 3 as a guardian of the tumor microenvironment. , 2016, Biochimica et biophysica acta.

[21]  Chenyue W. Hu,et al.  Progeny Clustering: A Method to Identify Biological Phenotypes , 2015, Scientific Reports.

[22]  K. Coombes,et al.  Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients , 2015, BBA clinical.

[23]  Gary D Bader,et al.  Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia. , 2015, Cancer cell.

[24]  He Huang,et al.  Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway , 2015, Journal of Hematology & Oncology.

[25]  Chuan Wu,et al.  Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. , 2014, Immunity.

[26]  Robert G. Parton,et al.  Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers , 2014, Nature Cell Biology.

[27]  H. Zhang,et al.  Autophagy Induced by Calcium Phosphate Precipitates Targets Damaged Endosomes* , 2014, The Journal of Biological Chemistry.

[28]  Y. Harazono,et al.  Why anti-Bcl-2 clinical trials fail: a solution , 2014, Cancer and Metastasis Reviews.

[29]  K. Coombes,et al.  Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells , 2013, PloS one.

[30]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[31]  Chieh-Yu Liu,et al.  Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia. , 2013, Blood.

[32]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[33]  A. Kohara,et al.  Protein Kinase C Regulates Human Pluripotent Stem Cell Self-Renewal , 2013, PloS one.

[34]  R. Davis,et al.  Prognostic impact and targeting of CRM1 in acute myeloid leukemia. , 2012, Blood.

[35]  Huamin Wang,et al.  Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling , 2012, PloS one.

[36]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[37]  T. Taki,et al.  Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia , 2011, Proceedings of the National Academy of Sciences.

[38]  K. Coombes,et al.  Low Expression Of PP2A Regulatory Subunit B55α Is Associated With T308 Phosphorylation Of AKT And Shorter Complete Remission Duration In Acute Myeloid Leukemia Patients , 2011, Leukemia.

[39]  A. Basu,et al.  Two Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death , 2010, TheScientificWorldJournal.

[40]  V. Ruvolo,et al.  Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells , 2010, Journal of signal transduction.

[41]  J. Gribben,et al.  GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death. , 2010, Blood.

[42]  Z. Berková,et al.  Milatuzumab – a promising new immunotherapeutic agent , 2010, Expert opinion on investigational drugs.

[43]  J. Bernhagen,et al.  A functional heteromeric MIF receptor formed by CD74 and CXCR4 , 2009, FEBS letters.

[44]  J. Rhodes,et al.  Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. , 2009, Cancer research.

[45]  M. Hung,et al.  Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. , 2009, Cancer research.

[46]  T. Niki,et al.  Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. , 2008, Glycobiology.

[47]  L. Leng,et al.  Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex* , 2008, Journal of Biological Chemistry.

[48]  D. Denhardt,et al.  Control of osteopontin signaling and function by post‐translational phosphorylation and protein folding , 2007, Journal of cellular biochemistry.

[49]  E. Dahl,et al.  Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity , 2007, Oncogene.

[50]  L. Leng,et al.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.

[51]  J. Bernhagen,et al.  Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. , 2006, Cellular signalling.

[52]  V. Kuchroo,et al.  The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity , 2005, Nature Immunology.

[53]  H. Kuwano,et al.  Implication of galectin-3 in Wnt signaling. , 2005, Cancer research.

[54]  D. Goldenberg,et al.  Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. , 2004, Blood.

[55]  David M. Goldenberg,et al.  CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy , 2004, Clinical Cancer Research.

[56]  Y. Takenaka,et al.  Galectin-3, a Novel Binding Partner of β-Catenin , 2004, Cancer Research.

[57]  Y. Kloog,et al.  Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.

[58]  L. Leng,et al.  MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.

[59]  R. Weichselbaum,et al.  Proteolytic activation of protein kinase C delta by an ICE‐like protease in apoptotic cells. , 1995, The EMBO journal.

[60]  P. Ruvolo.  Galectins as regulators of cell survival in the leukemia niche. , 2019, Advances in biological regulation.

[61]  M. Taniwaki,et al.  Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells. , 2014, Leukemia research.

[62]  J. Bernhagen,et al.  Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. , 2011, Cellular signalling.

[63]  Y. Takenaka,et al.  Galectin-3, a novel binding partner of beta-catenin. , 2004, Cancer research.

[64]  A. Raz,et al.  BH 1 ( NWGR ) Domain of Bcl-2 Family Galectin-3 : A Novel Antiapoptotic Molecule with A Functional Updated , 2006 .